Taeumjowi-tang, a Traditional Korean Sasang Remedy, Improves Obesity-Atopic Dermatitis Comorbidity by Regulating Hypoxia-Inducible Factor 1 Alpha.
Journal: 2020/January - Frontiers in Pharmacology
ISSN: 1663-9812
Abstract:
Atopic dermatitis (AD) is an inflammatory disease of the skin, resulting from an immune dysfunction, that often occurs as a comorbidity of obesity. This investigation evaluated the capacity of Taeumjowi-tang (TJT), a Korean herbal formulation from the Sasang medical tradition to influence prognostic features of AD and obesity in a mouse model. Here, obesity and AD were induced by a high-fat diet (HFD) and 1-fluoro-2,4-dinitrobenzene (DNFB). Following an 8-week HFD regimen and 4 weeks of DNFB administration, the comorbid (CO) group manifested increased body weight and AD-like lesions, as compared to normal control (NC) mice, while TJT administration diminished these symptoms of obesity and AD. Specifically, TJT treatment reduced epidermal thickness and eosinophil/mast cell infiltration, along with reduction in immunoglobulin E, interleukin (IL)-4, IL-6, and tumor necrosis factor-alpha (TNF-α). It was additionally demonstrated that TJT suppresses HFD/DNFB-associated increase of the inflammation-related nuclear factor-kappa beta (NF-κB) and mitogen activated protein kinase. Moreover, significantly increased levels of hypoxia inducible factor-1 alpha (HIF-1α) protein was observed in CO group versus controls, an increase significantly down-regulated by TJT-treatment. These outcomes suggest that TJT may prove useful in clinical management of obesity-AD comorbidity treatment, an effect that may be due to regulation of HIF-1α expression.
Relations:
Content
Citations
(1)
Diseases
(1)
Conditions
(2)
Chemicals
(7)
Genes
(2)
Processes
(1)
Anatomy
(2)
Similar articles
Articles by the same authors
Discussion board
Front Pharmacol 10: 1458

Taeumjowi-tang, a Traditional Korean Sasang Remedy, Improves Obesity-Atopic Dermatitis Comorbidity by Regulating Hypoxia-Inducible Factor 1 Alpha

Click here for additional data file.(322K, pdf)
Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul, South Korea,
Comorbidity Research Institute, Kyung Hee University, Seoul, South Korea,
Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, South Korea,
Department of Life Science, College of Natural Sciences, Kyonggi University, Suwon, South Korea,
Edited by: Mohamed Eddouks, Moulay Ismail University, Morocco
Reviewed by: Mohammad Sarwar Alam, Jamia Hamdard University, India; Jianping Chen, Shenzhen Traditional Chinese Medicine Hospital, China
*Correspondence: Jae-Young Um, rk.ca.uhk@muyj
This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology
†These authors have contributed equally to this work
Edited by: Mohamed Eddouks, Moulay Ismail University, Morocco
Reviewed by: Mohammad Sarwar Alam, Jamia Hamdard University, India; Jianping Chen, Shenzhen Traditional Chinese Medicine Hospital, China
Received 2019 May 8; Accepted 2019 Nov 13.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Abstract

Atopic dermatitis (AD) is an inflammatory disease of the skin, resulting from an immune dysfunction, that often occurs as a comorbidity of obesity. This investigation evaluated the capacity of Taeumjowi-tang (TJT), a Korean herbal formulation from the Sasang medical tradition to influence prognostic features of AD and obesity in a mouse model. Here, obesity and AD were induced by a high-fat diet (HFD) and 1-fluoro-2,4-dinitrobenzene (DNFB). Following an 8-week HFD regimen and 4 weeks of DNFB administration, the comorbid (CO) group manifested increased body weight and AD-like lesions, as compared to normal control (NC) mice, while TJT administration diminished these symptoms of obesity and AD. Specifically, TJT treatment reduced epidermal thickness and eosinophil/mast cell infiltration, along with reduction in immunoglobulin E, interleukin (IL)-4, IL-6, and tumor necrosis factor-alpha (TNF-α). It was additionally demonstrated that TJT suppresses HFD/DNFB-associated increase of the inflammation-related nuclear factor-kappa beta (NF-κB) and mitogen activated protein kinase. Moreover, significantly increased levels of hypoxia inducible factor-1 alpha (HIF-1α) protein was observed in CO group versus controls, an increase significantly down-regulated by TJT-treatment. These outcomes suggest that TJT may prove useful in clinical management of obesity-AD comorbidity treatment, an effect that may be due to regulation of HIF-1α expression.

Keywords: comorbidity, atopic dermatitis, obesity, Taeumjowi-tang, hypoxia-inducible factor 1 alpha
Abstract
Click here for additional data file.(322K, pdf)
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.